By Yasuko Kii, BE Tokyo
Eisai has established its pharmaceutical manufacturing subsidiary “Eisai Manufacturing Ltd.” (EML) in Hatfield, UK.
EML is owned by the company’s EHQs, Eisai Europe Limited, and will function as the core base of quality assurance and supply chain management for the Eisai’s operations in Europe. EML is planning to launch the operation by 2008 and will recruit experts.
Health Minister Lord Hunt said: "One of the major strengths of having a successful research-based industry in the UK is that patients here can be the first to benefit through involvement in clinical trials, and then by early access to cost-effective innovative medicines.
"Eisai's decision to site its European Knowledge Centre in Hatfield shows the UK remains an attractive country for global companies to invest in."
Printable Version
Email this page
Add to My UK